UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000016987
Receipt number R000019697
Scientific Title A prospective study of the natural history of pancreatic cyst including branch duct type intraductal papillary mucinous neoplasms of the pancreas
Date of disclosure of the study information 2015/03/31
Last modified on 2019/08/05 17:59:37

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A prospective study of the natural history of pancreatic cyst including branch duct type intraductal papillary mucinous neoplasms of the pancreas

Acronym

A prospective study of the natural history of pancreatic cyst including branch duct type IPMN

Scientific Title

A prospective study of the natural history of pancreatic cyst including branch duct type intraductal papillary mucinous neoplasms of the pancreas

Scientific Title:Acronym

A prospective study of the natural history of pancreatic cyst including branch duct type IPMN

Region

Japan


Condition

Condition

Non-specific pancreatic cyst and branch duct type intraductal papillary mucinous neoplasm of the pancreas

Classification by specialty

Hepato-biliary-pancreatic medicine

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

Branch duct type IPMN (BD-IPMN), which is representative cystic lesion of the pancreas, is associated with the pancreatic carcinogenesis, such as a malignant transformation of IPMN itself and a concomitant onset of pancreatic ductal adenocarcinoma. Though the small cysts of the pancreas sometimes cannot be classified with the specific cystic disease of the pancreas by imaging studies, some clinical and pathological reports indicate that most of those "non-specific" cysts of the pancreas are biologically similar with IPMN. Based on this insight, the recommendation of the clinical examinations for small cystic lesion including small BD-IPMN in every 2-3 years by the international guideline may be inadequate.
In response to the above, since September 2012 in our medical center, the imaging examinations in every 6 months have been performed for all the follow-up patients with BD-IPMN or non-specific pancreatic cyst. To estimate the risk of pancreatic carcinogenesis in those subjects and the contribution to the prognosis by the close follow-up, we designed a long-term and prospective cohort study.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The rate of pancreatic carcinogenesis in patients with non-specific pancreatic cyst or branch duct type intraductal papillary mucinous neoplasm of the pancreas

Key secondary outcomes

1) Prognosis of the subjects
2) The rate of progression of the pancreatic lesion


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

The patients with BD-IPMN or non-specific pancreatic cyst.

Key exclusion criteria

1) A concurrence of pancreatic malignancies at the time of diagnosis of IPMN.
2) The contraindication or rejection for the imaging examinations by EUS or MRCP.
3) The patients from whom the informed consent cannot be obtained.
4) The patients who are judged inappropriate for the participation for this study by the attending doctor.

Target sample size

600


Research contact person

Name of lead principal investigator

1st name Shinsuke
Middle name
Last name Koshita

Organization

Sendai City Medical Center

Division name

Department of Gastroenterology

Zip code

983-0824

Address

5-22-1, Tsurugaya, MIyagino-ku, Sendai, Japan

TEL

+81-22-252-1111

Email

skoshita@openhp.or.jp


Public contact

Name of contact person

1st name Shinsuke
Middle name
Last name Koshita

Organization

Sendai City Medical Center

Division name

Department of Gastroenterology

Zip code

983-0824

Address

5-22-1, Tsurugaya, MIyagino-ku, Sendai, Japan

TEL

+81-22-252-1111

Homepage URL


Email

skoshita@openhp.or.jp


Sponsor or person

Institute

Sendai City Medical Center

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Sendai City Medical Center

Address

5-22-1, Tsurugaya, MIyagino-ku, Sendai, Japan

Tel

+81-22-252-1111

Email

skoshita@openhp.or.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2015 Year 03 Month 31 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2012 Year 10 Month 01 Day

Date of IRB

2012 Year 09 Month 28 Day

Anticipated trial start date

2013 Year 02 Month 01 Day

Last follow-up date

2021 Year 01 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

prospective cohort study


Management information

Registered date

2015 Year 03 Month 31 Day

Last modified on

2019 Year 08 Month 05 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000019697


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name